A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according to a presentation today at the ...
Mar 5, 2024
0
0
Your liver plays a vital role in your metabolism, the biological process that converts food into energy. We know that being overweight can negatively affect metabolic activity, but not exactly how. To better understand this, ...
Feb 26, 2024
0
1
Glucagon, a hormone best known for promoting blood sugar production in the liver, also appears to play a key role in maintaining kidney health. When UT Southwestern Medical Center researchers removed receptors for this hormone ...
Feb 23, 2024
0
57
The gut microbiome interacts with the loss of female sex hormones to exacerbate metabolic disease, including weight gain, fat in the liver and the expression of genes linked with inflammation, researchers found in a new rodent ...
Feb 22, 2024
0
52
The importance of lipids as one of the fundamental biological compounds is well established as they are important signaling molecules and key components of metabolic disorders. The imbalance in lipid homeostasis and the dysregulation ...
A study led by the University of Barcelona and the Biomedical Research Networking Center in Diabetes and Associated Metabolic Disorders (CIBERDEM) reveals how a new mechanism could improve the efficiency of currently available ...
Feb 12, 2024
0
1
Researchers at Karolinska Institutet have developed a method to study liver function and disease without requiring invasive procedures. After transplanting liver cells into the eye of mice, the cornea can be used as a window ...
Feb 1, 2024
0
35
Investigators from the Smidt Heart Institute at Cedars-Sinai and colleagues found that women with fatty liver disease related to alcohol consumption have almost twice the risk of dying within a certain time period than men ...
Jan 25, 2024
0
0
Metabolic dysfunction-associated steatohepatitis, or MASH, is an inflammatory, liver-scarring disease that has reached epidemic proportions, with an estimated 1.5% to 6.5% of U.S. adults afflicted by the condition, and roughly ...
Jan 23, 2024
0
0
Ozempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes and chronic liver disease, according to a nationwide study from Karolinska Institutet ...
Jan 23, 2024
0
89
